Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children’s Hospital experience

Erin Crotty(Seattle Children's Hospital), Sarah Leary(Seattle Children's Hospital), J. Russell Geyer(Seattle Children's Hospital), James M. Olson(Seattle Children's Hospital), Nathan E. Millard(Seattle Children's Hospital), Aimee Sato(University of Washington), Ralph P. Ermoian(University of Washington), Bonnie Cole(Seattle Children's Hospital), Christina M. Lockwood(Seattle Children's Hospital), Vera Paulson(Seattle Children's Hospital), Samuel R. Browd(Seattle Children's Hospital), Richard G. Ellenbogen(Seattle Children's Hospital), Jason S. Hauptman(Seattle Children's Hospital), Amy Lee(Seattle Children's Hospital), Jeffrey G. Ojemann(Seattle Children's Hospital), Nicholas A. Vitanza(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Journal of Neuro-Oncology
June 16, 2020
Cited by 35

Abstract


Related Papers